176 related articles for article (PubMed ID: 8233284)
21. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
23. Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil.
Jakubowski AA; Kemeny N
Cancer; 1988 Jul; 62(2):266-9. PubMed ID: 3383127
[TBL] [Abstract][Full Text] [Related]
24. [Acute cardiotoxicity from 5-fluorouracil: un underestimated toxicity].
Bertolini A; Fiumanò M; Muffatti A; Pedroncelli S; Doria A; Codazzi G; Giustiniani S; Scarinci A; Redaelli G
Minerva Cardioangiol; 1999; 47(7-8):269-73. PubMed ID: 10582438
[TBL] [Abstract][Full Text] [Related]
25. Fluorouracil cardiotoxicity.
Anand AJ
Ann Pharmacother; 1994 Mar; 28(3):374-8. PubMed ID: 8193429
[TBL] [Abstract][Full Text] [Related]
26. [Dose-intensive chemotherapy with continuous infusion 5-fluorouracil].
Tichler T; Ghodsizade E; Katz A; Rath P; Berger R; Brenner H
Harefuah; 1999 Nov; 137(9):387-90, 430. PubMed ID: 11419042
[TBL] [Abstract][Full Text] [Related]
27. Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients.
Seker M; Isen HC; Çevirme N; Aydın S; Bilici A; Bulut H; Yasin AI; Coban E; Demir T; Aliyev A; Kocyigit A; Turk HM
Oncol Res Treat; 2018; 41(9):545-549. PubMed ID: 30121640
[TBL] [Abstract][Full Text] [Related]
28. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
29. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen.
Barutca S; Ceyhan C; Meydan N; Ozturk B; Tekten T; Onbasili A; Kadikoylu G; Bolaman Z
Chemotherapy; 2004 Jun; 50(3):113-8. PubMed ID: 15272225
[TBL] [Abstract][Full Text] [Related]
30. 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?
Steger F; Hautmann MG; Kölbl O
Radiat Oncol; 2012 Dec; 7():212. PubMed ID: 23241239
[TBL] [Abstract][Full Text] [Related]
31. Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer.
Wein A; Riedel C; Brückl W; Kastl S; Reingruber B; Hohenberger W; Hahn EG
Z Gastroenterol; 2001 Feb; 39(2):153-6. PubMed ID: 11253506
[TBL] [Abstract][Full Text] [Related]
32. Concomitant administration of 4-hydroxypyrazolopyrimidine (allopurinol) and high-dose continuous infusion 5-fluorouracil.
Tsavaris N; Karagiaouris P; Vonorta K; Bacogianis H; Milonakis N; Karvounis N; Kakoliris S; Zepou E; Karabelis A; Papazahariou M
Oncology; 1990; 47(1):70-4. PubMed ID: 2300389
[TBL] [Abstract][Full Text] [Related]
33. Clinical cardiotoxicity of 5-fluorouracil.
Keefe DL; Roistacher N; Pierri MK
J Clin Pharmacol; 1993 Nov; 33(11):1060-70. PubMed ID: 8300889
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of 5-Fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer.
Aiura K; Takahashi S; Matsui J; Ueda M; Kitagawa Y
Pancreatology; 2010; 10(2-3):250-8. PubMed ID: 20484963
[TBL] [Abstract][Full Text] [Related]
35. Electrocardiographic changes simulating acute myocardial infarction or ischemia associated with combination chemotherapy with etoposide, cisplatin, and 5-fluorouracil.
Lee KH; Lee JS; Kim SH
Korean J Intern Med; 1990 Jul; 5(2):112-7. PubMed ID: 2098095
[TBL] [Abstract][Full Text] [Related]
36. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel in combination with fluorouracil for advanced solid tumors.
Burris HA
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
[TBL] [Abstract][Full Text] [Related]
38. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
[TBL] [Abstract][Full Text] [Related]
39. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
